Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 1
1975 1
1976 1
1977 2
1982 1
1983 3
1984 1
1986 4
1988 1
1990 2
1991 2
1992 3
1993 2
1994 5
1995 3
1996 7
1997 4
1998 3
1999 5
2000 1
2001 3
2002 3
2003 2
2004 1
2005 3
2006 3
2007 4
2008 13
2009 10
2010 6
2011 7
2012 7
2013 7
2014 5
2015 7
2016 5
2017 9
2018 3
2019 6
2020 10
2021 7
2022 9
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

171 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.
Mugarza E, van Maldegem F, Boumelha J, Moore C, Rana S, Llorian Sopena M, East P, Ambler R, Anastasiou P, Romero-Clavijo P, Valand K, Cole M, Molina-Arcas M, Downward J. Mugarza E, et al. Among authors: east p. Sci Adv. 2022 Jul 22;8(29):eabm8780. doi: 10.1126/sciadv.abm8780. Epub 2022 Jul 20. Sci Adv. 2022. PMID: 35857848 Free PMC article.
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
Coelho MA, de Carné Trécesson S, Rana S, Zecchin D, Moore C, Molina-Arcas M, East P, Spencer-Dene B, Nye E, Barnouin K, Snijders AP, Lai WS, Blackshear PJ, Downward J. Coelho MA, et al. Among authors: east p. Immunity. 2017 Dec 19;47(6):1083-1099.e6. doi: 10.1016/j.immuni.2017.11.016. Epub 2017 Dec 12. Immunity. 2017. PMID: 29246442 Free PMC article.
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.
Boumelha J, de Carné Trécesson S, Law EK, Romero-Clavijo P, Coelho MA, Ng KW, Mugarza E, Moore C, Rana S, Caswell DR, Murillo M, Hancock DC, Argyris PP, Brown WL, Durfee C, Larson LK, Vogel RI, Suárez-Bonnet A, Priestnall SL, East P, Ross SJ, Kassiotis G, Molina-Arcas M, Swanton C, Harris R, Downward J. Boumelha J, et al. Among authors: east p. Cancer Res. 2022 Oct 4;82(19):3435-3448. doi: 10.1158/0008-5472.CAN-22-0325. Cancer Res. 2022. PMID: 35930804 Free PMC article.
Selective advantage of epigenetically disrupted cancer cells via phenotypic inertia.
Loukas I, Simeoni F, Milan M, Inglese P, Patel H, Goldstone R, East P, Strohbuecker S, Mitter R, Talsania B, Tang W, Ratcliffe CDH, Sahai E, Shahrezaei V, Scaffidi P. Loukas I, et al. Among authors: east p. Cancer Cell. 2023 Jan 9;41(1):70-87.e14. doi: 10.1016/j.ccell.2022.10.002. Epub 2022 Nov 3. Cancer Cell. 2023. PMID: 36332625 Free article.
Early-life adversity is associated with poor iron status in infancy.
Reid BM, East P, Blanco E, Doom JR, Burrows RA, Correa-Burrows P, Lozoff B, Gahagan S. Reid BM, et al. Among authors: east p. Dev Psychopathol. 2022 Jun 9:1-12. doi: 10.1017/S0954579422000517. Online ahead of print. Dev Psychopathol. 2022. PMID: 35678178
Dual ancestries and ecologies of the Late Glacial Palaeolithic in Britain.
Charlton S, Brace S, Hajdinjak M, Kearney R, Booth T, Reade H, Tripp JA, Sayle KL, Grimm SB, Bello SM, Walker EA, Gilardet A, East P, Glocke I, Larson G, Higham T, Stringer C, Skoglund P, Barnes I, Stevens RE. Charlton S, et al. Among authors: east p. Nat Ecol Evol. 2022 Nov;6(11):1658-1668. doi: 10.1038/s41559-022-01883-z. Epub 2022 Oct 24. Nat Ecol Evol. 2022. PMID: 36280785 Free PMC article.
171 results